- Report
- January 2024
- 200 Pages
Global
From €2403EUR$2,490USD£2,062GBP
- Report
- January 2024
- 386 Pages
Global
€4821EUR$4,995USD£4,136GBP
- Report
- April 2023
- 175 Pages
Global
From €5694EUR$5,899USD£4,884GBP
- Drug Pipelines
- October 2020
- 98 Pages
Global
From €1930EUR$2,000USD£1,656GBP
Doxycycline is an antibiotic used to treat a variety of bacterial infections, including those caused by immune disorders. It is a tetracycline antibiotic, which works by inhibiting the growth of bacteria. It is commonly used to treat infections caused by Streptococcus pneumoniae, Haemophilus influenzae, and Mycoplasma pneumoniae. It is also used to treat Lyme disease, acne, and other skin conditions. Doxycycline is available in both oral and intravenous forms.
The doxycycline market is highly competitive, with many companies offering generic and branded versions of the drug. Companies such as Pfizer, Merck, and Teva Pharmaceuticals are some of the major players in the market. Other companies include Mylan, Sandoz, and Sun Pharmaceuticals. Show Less Read more